Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Noel

Showing results (501-510 of 787) with videos related to

Pageof 79
Sort By:
American Heart Journal|September 5, 2024
Contributors to high left ventricular ejection fraction in women with ischemia and no obstructive coronary artery disease: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) StudyMichael D Nelson, Joanne M Gomez-Arnold, Janet Wei, et al.
Heart (British Cardiac Society)|June 14, 2023
Left ventricular ejection fraction and long-term outcomes in women presenting with signs and symptoms of ischaemiaStephanie Wu, Janet Wei, Marie Lauzon, et al.
Journal of the American Heart Association|June 6, 2019
Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute-Sponsored Women's Ischemia Syndrome EvaluationJulie J Lee, Galen Cook-Wiens, B Delia Johnson, et al.
American Journal of Human Genetics|November 28, 2002
Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) studyQi Chen, Steven E Reis, Candace M Kammerer, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2008
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart diseaseGlenn D Braunstein, B Delia Johnson, Frank Z Stanczyk, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2004
A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
JACC. Cardiovascular Interventions|August 22, 2020
Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and WhenThomas J Ford, Peter Ong, Udo Sechtem, et al.
Cardiovascular Diagnosis and Therapy|January 1, 2024
Association of abnormal electrocardiography response on dobutamine stress echocardiogram with longer-term major adverse cardiovascular events in women with symptoms of ischemic heart diseaseSachini Ranasinghe, Benita Tjoe, Chrisandra Shufelt, et al.
European Heart Journal|February 23, 2022
Heart-brain interactions in cardiac and brain diseases: why sex mattersAlexia Rossi, Nidaa Mikail, Susan Bengs, et al.
Menopause (New York, N.Y.)|May 5, 2021
Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health InitiativeRobert A Wild, Kathleen M Hovey, Christopher Andrews, et al.
Pageof 79

Showing results (501-510 of 787) with videos related to

Sort By:
Pageof 79
American Heart Journal|September 5, 2024
Contributors to high left ventricular ejection fraction in women with ischemia and no obstructive coronary artery disease: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) StudyMichael D Nelson, Joanne M Gomez-Arnold, Janet Wei, et al.
Heart (British Cardiac Society)|June 14, 2023
Left ventricular ejection fraction and long-term outcomes in women presenting with signs and symptoms of ischaemiaStephanie Wu, Janet Wei, Marie Lauzon, et al.
Journal of the American Heart Association|June 6, 2019
Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute-Sponsored Women's Ischemia Syndrome EvaluationJulie J Lee, Galen Cook-Wiens, B Delia Johnson, et al.
American Journal of Human Genetics|November 28, 2002
Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) studyQi Chen, Steven E Reis, Candace M Kammerer, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2008
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart diseaseGlenn D Braunstein, B Delia Johnson, Frank Z Stanczyk, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2004
A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
JACC. Cardiovascular Interventions|August 22, 2020
Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and WhenThomas J Ford, Peter Ong, Udo Sechtem, et al.
Cardiovascular Diagnosis and Therapy|January 1, 2024
Association of abnormal electrocardiography response on dobutamine stress echocardiogram with longer-term major adverse cardiovascular events in women with symptoms of ischemic heart diseaseSachini Ranasinghe, Benita Tjoe, Chrisandra Shufelt, et al.
European Heart Journal|February 23, 2022
Heart-brain interactions in cardiac and brain diseases: why sex mattersAlexia Rossi, Nidaa Mikail, Susan Bengs, et al.
Menopause (New York, N.Y.)|May 5, 2021
Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health InitiativeRobert A Wild, Kathleen M Hovey, Christopher Andrews, et al.
Pageof 79